Anterix
ATEX
Anterix (ATEX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $130.00 from $133.00 | Aug 13, 2026 |
| JP Morgan | Maintained | Overweight | $133.00 from $50.00 | Jul 20, 2026 |
| B. Riley Securities | Downgraded | Buy → Neutral | $69.00 from $44.00 | Jun 4, 2026 |
| JP Morgan | Maintained | Overweight | $50.00 from $67.00 | Oct 17, 2025 |
| JP Morgan | Maintained | Overweight | $67.00 from $61.00 | Feb 13, 2025 |
| JP Morgan | Maintained | Overweight | $61.00 from $60.00 | Aug 8, 2024 |
| B. Riley Securities | Maintained | Buy | $75.00 | Feb 16, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $41.00 from $42.00 | Aug 1, 2023 |
Frequently asked questions
What is the latest analyst rating on ATEX?
On Aug 13, 2026, JP Morgan maintained Anterix at Overweight with a price target of $130.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.